CRINETICS PHARMACEUTICALS IN shareholders Q2 2024

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 234 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.

CRINETICS PHARMACEUTICALS IN shareholders Q2 2024
NameSharesValueWeighting ↓
Orbimed Advisors 1,280,800$57,367,0321.13%
Lisanti Capital Growth, LLC 83,380$3,734,5900.90%
Parkman Healthcare Partners LLC 141,375$6,332,1860.85%
Resolute Capital Asset Partners LLC 30,000$1,3440.77%
Artia Global Partners LP 85,765$3,841,4140.74%
Pier Capital, LLC 108,545$4,861,7310.72%
ADAR1 Capital Management, LLC 74,850$3,352,5320.63%
HighVista Strategies LLC 35,237$1,578,2650.58%
Eventide Asset Management 735,088$32,924,5920.56%
HighMark Wealth Management LLC 19,995$895,5760.54%
Duquesne Family Office 309,000$13,8400.47%
Lewis Asset Management, LLC 12,395$555,1720.42%
EAM Investors, LLC 57,179$2,561,0470.42%
Rock Springs Capital Management LP 289,400$12,962,2260.39%
Hood River Capital Management LLC 410,342$18,379,2180.38%
AWM Investment Company, Inc. 55,000$2,463,4500.33%
Point72 Asset Management, L.P. 2,780,856$124,554,5400.33%
Nicholas Investment Partners, LP 53,012$2,374,4070.25%
MAPLELANE CAPITAL, LLC 160,000$7,166,4000.24%
Schonfeld Strategic Advisors LLC 653,557$29,272,8160.19%
External links

This page lists CRINETICS PHARMACEUTICALS IN's shareholders in Q2 2024. To view CRINETICS PHARMACEUTICALS IN's shareholder history, click here.